LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $1.0B
- YoY, 2025
- +22.5%
- 5-year CAGR
- +7.5%
- 10-year CAGR
- +15.7%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $1.0B | +22.5% |
| 2024 | $830M | +18.5% |
| 2023 | $701M | +17.3% |
| 2022 | $597M | −27.2% |
| 2021 | $821M | +15.7% |
| 2020 | $710M | −7.5% |
| 2019 | $767M | +36.8% |
| 2018 | $561M | +40.3% |
| 2017 | $400M | +17.1% |
| 2016 | $341M | +43.8% |
| 2015 | $237M | +801.6% |
| 2014 | $26M | −47.0% |
| 2013 | $50M | +87.3% |
| 2012 | $26M | +223.6% |
| 2011 | $8.2M | — |
| 2010 | −$4.9M | — |
| 2009 | $3.7M | — |